Clinical Trials in Pennsylvania

Showing 19401-19420 of 19,675 trials

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

NCT00110864

This study is designed to evaluate the safety and efficacy of PN2034 in insulin-dependent type 2 diabetics as measured by the change in average daily insulin dose from baseline to week 12. The effects of PN2034 on HbA1c, fasting plasma glucose (FPG), and lipid levels will also be measured.

Type 2 Diabetes Mellitus

Wellstat Therapeutics90 participantsStarted May 2005

Waterbury, Connecticut, United States • Hollywood, Florida, United States • Longwood, Florida, United States +15 more locations

COMPLETEDPhase 229 miles

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

NCT00110851

This study is designed to evaluate the safety and efficacy of PN2034 administered to type 2 diabetics on concomitant rosiglitazone and metformin (or Avandamet) therapy as measured by change in glycosylated hemoglobin (HbA1c) levels from baseline to Week 12. Also the study will evaluate the effect of PN2034 on glucose control as measured by fasting plasma glucose (FPG) and on fasting lipid levels: triglycerides, total cholesterol, high-density lipoproteins (HDL), low-density lipoproteins (LDL), and very low-density lipoproteins (VLDL).

Type 2 Diabetes Mellitus

Wellstat Therapeutics90 participantsStarted Apr 2005

Waterbury, Connecticut, United States • DeLand, Florida, United States • Hollywood, Florida, United States +17 more locations

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

Find Trials by Condition in Pennsylvania

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

Three-Part Program for Parents With Premature Infants

Pennsylvania Adolescent Intervention Research Study (PAIRStudy)

Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon

A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal Odor Not Caused by BV or Vaginitis

Study of Antiepileptic Drug Effects on Child Development

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration

Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent